Table 3.

Factors associated with fatigue

	Bivariate		Multivariate
	OR (95% CI)	p-value	OR (95% CI)	p-value
Age	1.032 (0.995–1.071)	0.089	–	–
PSA	1.001 (0.999–1.003)	0.464	–	–
Testosterone	0.984 (0.956–1.012)	0.248	–	–
Hb	0.821 (0.666–1.012)	0.065	–	–
LDH	0.999 (0.996–1.003)	0.680	–	–
ALP	1.001 (0.998–1.005)	0.503	–	–
Albumin	0.404 (0.159–1.025)	0.056	–
Sodium	0.889 (0.782–1.010)	0.071	–	–
Alcohol consumption	2.750 (0.793–9.542)	0.111	–	–
Regular exercise	0.550 (0.294–1.031)	0.062	–
Diabetes mellitus	1.918 (0.873–4.212)	0.105	–	–
Cardiovascular disorders	4.884 (1.676–14.233)	0.004	4.7 (1.6–13.9)	0.005
Respiratory disorders	3.800 (1.113–12.969)	0.033	3.6 (1.0–12.5)	0.043
High blood pressure	1.522 (0.843–2.746)	0.163	–	–
Sleep disturbances	3.982 (0.503–31.511)	0.191	–	–
Time since diagnosis	1.054 (0.981–1.132)	0.150	–
Surgical castration	0.246 (0.53–1.131)	0.072	–	–
Chemical castration	0.000 (0.000-)	1.000	–	–
Radical prostatectomy at diagnosis	0.578 (0.273–1.225)	0.153	–	–
External radiation therapy at diagnosis	1.747 (0.792–3.851)	0.167	–	–
Duration of previous LHRH therapy		0.757
7–12 months	1.000 (0.084–11.931)	1.000	–	–
13–18 months	0.583 (0.052–6.587)	0.663	–	–
19–24 months	1.111 (0.097–12.750)	0.933	–	–
25–35 months	0.905 (0.080–10.210)	0.935	–	–
36–47 months	0.857 (0.076–9.695)	0.901	–	–
48–59 months	0.571 (0.049–6.606)	0.654	–	–
≥ 60 months	1.333 (0.131–13.586)	0.808	–	–
Urinary catheter	3.857 (0.527–28.241)	0.184	–	–
Haematuria	4.370 (0.556–34.346)	0.161	–	–

CI Confidence interval, Hb Haemoglobin, LDH Lactate dehydrogenase, LHRH Luteinizing hormone-releasing hormone, OR Odds ratio, PSA Prostate-specific antigen